What are the indications for pleurodesis in primary spontaneous pneumothorax, secondary spontaneous pneumothorax (including active tuberculosis cavity with hydropneumothorax and pyogenic infection-associated pneumothorax), traumatic pneumothorax, and malignant pleural effusions, and what criteria determine appropriate patient selection?

Pleurodesis Indications in Pneumothorax and Malignant Pleural Effusions

Primary Spontaneous Pneumothorax (PSP)

Pleurodesis in PSP should be reserved for recurrent cases or high-risk patients, not for first episodes. The BTS guidelines establish clear indications for surgical intervention including pleurodesis 1:

Definitive Indications for Pleurodesis in PSP:

• Second ipsilateral pneumothorax (recurrence on same side)
• First contralateral pneumothorax (opposite side involvement after previous pneumothorax)
• Bilateral spontaneous pneumothorax
• Persistent air leak >5-7 days despite tube drainage or failure to completely re-expand
• Spontaneous hemothorax
• High-risk professions (pilots, divers) - even after first episode

Important Caveats for PSP:

The evidence does NOT support surgical referral for persistent air leak in a first primary pneumothorax within 4-5 days 1. Studies show 100% of primary pneumothoraces with persistent air leaks >7 days resolved by 14 days with conservative management 1. However, protracted chest tube drainage beyond this timeframe is not in the patient's interest.

Chemical pleurodesis should only be attempted if the patient is unwilling or unable to undergo surgery 1. Surgical pleurodesis (via VATS or thoracotomy) has far lower recurrence rates than medical chemical pleurodesis 1.

---

Secondary Spontaneous Pneumothorax (SSP)

Earlier surgical intervention (including pleurodesis) is advocated for SSP, particularly at 3 days for persistent air leak, given the higher morbidity and mortality risk 1.

SSP Indications (Same as PSP but with lower threshold):

• Same criteria as PSP apply
• Earlier referral (2-4 days) should be considered for:
  • Underlying lung disease
  • Large persistent air leak
  • Failure of lung to re-expand 1

Special Considerations for Infection-Associated SSP:

For active TB cavity with hydropneumothorax or pyogenic infection-associated pneumothorax, chemical pleurodesis is generally CONTRAINDICATED during active infection. The evidence does not directly address pleurodesis in active TB or pyogenic infections, but standard practice dictates:

1. Active TB pneumothorax: Manage with chest tube drainage and anti-TB therapy first 2. Pleurodesis should be deferred until infection is controlled.

2. Pyogenic infection-associated pneumothorax: This represents empyema with air leak - treat the infection first with drainage and antibiotics. Pleurodesis is not indicated during active infection due to risk of ARDS and empyema complications 1.

3. Post-infection recurrence prevention: Once infection is cleared and lung has re-expanded, standard SSP criteria for pleurodesis apply if recurrence occurs.

---

Traumatic Pneumothorax

Pleurodesis is NOT routinely indicated for traumatic pneumothorax. The provided guidelines focus exclusively on spontaneous pneumothorax. Traumatic pneumothorax is typically managed with:

• Observation (if small and stable)
• Chest tube drainage (if significant)
• Surgical repair if persistent air leak from structural injury

Pleurodesis would only be considered in the rare scenario of recurrent traumatic pneumothorax in high-risk individuals (e.g., military personnel, athletes in contact sports), but this is not evidence-based and should be individualized based on surgical consultation.

---

Malignant Pleural Effusions (MPE)

Talc pleurodesis is the most effective agent for MPE with a 93% success rate and should be offered to symptomatic patients with expandable lung 3.

Patient Selection Criteria for Pleurodesis in MPE:

Essential Prerequisites 3:

1. Significant symptoms (dyspnea, pain, cough) that are relieved when pleural fluid is evacuated
2. Complete lung re-expansion after fluid drainage
3. No bronchial obstruction
4. No trapped lung (fibrotic or tumor-entrapped lung)
5. Reasonable life expectancy (generally >3 months)

Key Predictors of Pleurodesis Failure:

• Pleural fluid pH <7.20 - strong predictor of trapped lung and short survival 4
• Non-expandable lung on imaging after drainage
• Loculated effusion

Treatment Algorithm for MPE:

Step 1: Symptomatic Assessment

• If asymptomatic: Do NOT perform pleural interventions 5
• If symptomatic: Proceed to Step 2

Step 2: Large-Volume Thoracentesis

• Perform to assess:
  • Symptom relief with fluid removal
  • Lung expandability 5

Step 3: Treatment Based on Lung Expansion

If Expandable Lung:

• Offer choice between indwelling pleural catheter (IPC) or talc pleurodesis 6, 5
• Talc is superior: 93% success vs 72% doxycycline, 67% tetracycline, 54% bleomycin 3
• Talc poudrage or talc slurry are equally effective 6, 5
• Dose: 2.5-10 g sterile talc (typically 5 g) 1

If Non-Expandable Lung, Failed Pleurodesis, or Loculated Effusion:

• Use IPC instead of pleurodesis 5
• Consider decortication surgery in highly selected fit patients 6

Contraindications to Pleurodesis in MPE:

• Corticosteroid therapy - stop or reduce dose as it decreases pleurodesis efficacy 3
• Trapped lung
• Expected survival <1 month
• Asymptomatic effusion

Pleurodesis Technique for MPE 3:

1. Insert chest tube (standard or small-bore 8-16F acceptable)
2. Confirm complete lung re-expansion radiographically
3. Administer IV narcotic/sedation (pain is common)
4. Instill sclerosing agent in 50-100 mL sterile saline
5. Clamp tube for 1 hour (patient rotation NOT required)
6. Apply 20 cm H₂O suction
7. Remove tube when output <150 mL/24 hours

Adverse Effects:

• Pain and fever most common 3
• ARDS and empyema rare but reported with talc 1

---

Key Pitfalls to Avoid:

1. Do NOT perform chemical pleurodesis for first PSP - surgery is preferred if intervention needed
2. Do NOT delay surgical referral beyond 5-7 days for persistent air leak in PSP, or 3 days in SSP
3. Do NOT attempt pleurodesis during active pleural infection (TB, empyema)
4. Do NOT perform pleurodesis in MPE with trapped lung - use IPC instead
5. Do NOT use tetracycline - 16% recurrence rate, inferior to talc 1
6. Do NOT perform pleurodesis in asymptomatic MPE - no benefit 5